OrganiGram Holdings Inc.
TSX:OGI.TODrug Manufacturers - Specialty & Generic
-$0.02 today
- Market cap
- $135.37M
- Beta
- 1.84
- P/E (TTM)
- -7.2
- EPS (TTM)
- -$0.19
Volume 0.54M
Average 0.19M
Dividends
OrganiGram Holdings Inc. dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
—
Shareholder Yield
0.00%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 0.0%, so compare payout growth against earnings coverage.
Competitor dividends
How does OrganiGram Holdings Inc. compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Eupraxia Pharmaceuticals Inc. TSX:EPRX.TO | $783.37M | 0.00% | $0.00 | 0.00% | 0.00% |
Fennec Pharmaceuticals Inc. TSX:FRX.TO | $580.71M | 0.00% | $0.00 | 0.00% | 0.00% |
Aurora Cannabis Inc. TSX:ACB.TO | $463.50M | 0.00% | $0.00 | 0.00% | 0.00% |
Auxly Cannabis Group Inc. TSX:XLY.TO | $365.45M | 0.00% | $0.00 | 0.00% | 0.00% |
Canopy Growth Corporation TSX:WEED.TO | $364.19M | 0.00% | $0.00 | 0.00% | 0.00% |
Cipher Pharmaceuticals Inc. TSX:CPH.TO | $360.13M | 0.00% | $0.00 | 0.00% | 1.63% |
Medical Facilities Corporation TSX:DR.TO | $274.81M | 2.00% | $0.36 | 20.36% | 8.29% |
TerrAscend Corp. TSX:TSND.TO | $201.10M | 0.00% | $0.00 | 0.00% | 0.13% |
HLS Therapeutics Inc. TSX:HLS.TO | $114.77M | 0.00% | $0.00 | 0.00% | 1.39% |
Questions
Dividend questions
Common questions about OGI.TO's dividend, answered from reported figures.
Does OGI.TO stock pay dividends?
OrganiGram Holdings Inc. (OGI.TO) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is OGI.TO's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.